Amsino International, Inc., a global manufacturer of single-use medical devices, announced the execution of an agreement with ...

Shingrix, a recombinant zoster vaccine, combines glycoprotein E antigen with an adjuvant system called AS01B. It has been ...

European Commission approves GSK’s recombinant zoster vaccine, Shingrix in prefilled syringe: London, UK Thursday, January 8, 2026, 09:00 Hrs [IST] GSK plc announced the Europea ...

Samsung Bioepis has started direct commercialisation of Byooviz, a biosimilar to Genentech’s Lucentis (ranibizumab), in ...

The Shrooms Update landed in Schedule 1 on December 26, 2025, as part of the v0.4.2 patch, introducing mushrooms as a new ...

Samsung Bioepis has begun direct commercialization of Byooviz in Europe. Byooviz is a biosimilar to Lucentis’ (ranibizumab).

Panelists discuss how aflibercept 8 mg maintains a safety profile similar to 2 mg and how workflow, systemic risk, and ...

A company claiming to be “America’s Largest Ophthalmic Pharmacy” has issued a recall for multiple eye drop products for the ...

GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of Olympus Partners and a leading U.S.

Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in systemic lupus erythematosus.

Hospital capacity across Michigan is "getting a little tight" with influenza cases, said Dr. Natasha Bagdasarian, the state's ...

Terumo Medical Corporation, a wholly-owned subsidiary of Terumo Corporation, announced the US launch of its SurTracttm Safety Syringe, powered by SafeR® passive safety technology developed by ...